Companies are realizing that they need to be more attuned to their audience
Today, we're all still trying to get people to buy our drugs and be a trusted health advisor, but these two goals seem to be working firmly against each other.
It may be time to adopt a model in which we help deliver healthcare
When you have a successful brand, you tamper with it at your peril
We cemented our credibility during the most difficult period for publishing
Since when was the US better at soccer than advertising?
A patient who is diagnosed earlier and receives the most efficacious treatment is the least expensive
Access to payers is about knowledge, about understanding what they do in their jobs
At MM&M's Leadership Exchange, the passion, candor, enthusiasm and respect were second-to-none
FDA has insisted that its antique regulations can address every new promotional challenge
Should pharma formulate a super matrix to determine the FMV of research incentives?
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.